| "Essential Business IP and Regulatory Issues for Emerging Life Sciences Companies" San Diego RTA. In order to succeed, an emerging life sciences company team must craft and implement a comprehensive business plan, protect its valuable intellectual property, and navigate through the complex regulatory waters posed by the FDA approval process. They must plan a strategy for assuring that Medicare and other government programs will pay for its product. See http://www.sdrta.org/upcoming.php?action=lifesciences04&menu=0 |
RSS